BPC-157 Dosing Protocol: Complete Research Guide

Also known as: Body Protection Compound-157, PL 14736

recovery

Research Reference Only

This information is for educational purposes only. BPC-157 is not FDA approved for human use. The protocols listed are summaries of published research studies and do not constitute medical advice. Always consult a licensed healthcare provider.

Overview

BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. Research has investigated its potential effects on tissue healing, angiogenesis, and cellular repair mechanisms.

Mechanisms of Action

Upregulates growth hormone receptor expression

Promotes angiogenesis via VEGF pathway

Modulates nitric oxide synthesis

Influences collagen formation and organization

Research Protocols

The following protocols are summaries of published research studies. They are presented for educational purposes only and do not constitute medical advice.

Protocol Name	Source	Dose	Frequency	Duration	Route	Evidence	Link
Tendon Healing Study	published study	10 μg/kg	Daily	14 days	Subcutaneous	animal
Gastric Ulcer Protocol	published study	10 μg/kg	Daily	7 days	Oral	animal

Related Studies

Stable gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon

animal

2010Journal of Orthopaedic Research

Animal Study

Summary

BPC-157 demonstrated significant acceleration of tendon healing in a rat model, with improved biomechanical properties and collagen organization compared to controls.

Limitations

Animal model only; results may not translate to humans. Small sample size.

View Original Study

Important Warnings

Safety Considerations

Limited human clinical data available
Not approved by FDA for human use
Long-term safety profile unknown